Determinants of growth hormone receptor down-regulation

Molecular Endocrinology

Volumn 21, Issue 7, 2007, Pages 1537-1551

  Deng, Luqin ^a   He, Kai ^b   Wang, Xiangdong ^b   Yang, Ning ^a   Thangavel, Chellappagounder ^c   Jiang, Jing ^b   Fuchs, Serge Y ^c   Frank, Stuart J ^a,b,d,e  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d BIRMINGHAM VA MEDICAL CENTER   (United States)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE RECEPTOR; JANUS KINASE 2; LACTACYSTIN; PROTEASOME INHIBITOR; PROTEIN SYNTHESIS INHIBITOR; TYROSINE;

ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME RECONSTITUTION; HORMONAL REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; UBIQUITINATION;

ACETYLCYSTEINE; ANIMALS; CELL LINE; CHLOROQUINE; CYCLOHEXIMIDE; DOWN-REGULATION; HUMAN GROWTH HORMONE; HUMANS; JANUS KINASE 2; LYSOSOMES; MICE; MUTATION; PHOSPHORYLATION; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN STRUCTURE, TERTIARY; PROTEIN SYNTHESIS INHIBITORS; RABBITS; RECEPTORS, SOMATOTROPIN; RECOMBINANT PROTEINS; TRANSFECTION; TYROSINE;

EID: 34347248826     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2007-0138     Document Type: Article

References (71)

1. Isaksson OG, Eden S, Jansson JO 1985 Mode of action of pituitary growth hormone on target cells. Annu Rev Physiol 47:483-499
2. Bartke A 2005 Minireview: role of the growth hormone/insulin-like growth factor system in mammalian aging. Endocrinology 146:3718-3723
3. Frank SJ, Messina JL 2002 Growth hormone receptor. In: Oppenheim JJ, Feldman M, eds. Cytokine reference online. London: Academic Press, Harcourt; 1-21
4. Carter Su C, Schwartz J, Smit LS 1996 Molecular mechanism of growth hormone action. Annu Rev Physiol 58:187-207
5. Bazan JF 1990 Structural design and molecular evolution of a cytokine receptor superfamily. Proc Natl Acad Sci USA 87:6934-6938
6. Argetsinger LS, Campbell GS, Yang X, Witthuhn BA, Silvennoinen O, Ihle JN, Carter-Su C 1993 Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase. Cell 74:237-244
7. Silvennoinen O, Witthuhn BA, Quelle FW, Cleveland JL, Yi T, Ihle JN 1993 Structure of the murine Jak2 protein-tyrosine kinase and its role in interleukin 3 signal transduction. Proc Natl Acad Sci USA 90:8429-8433
8. Gent J, van Kerkhof P, Roza M, Bu G, Strous GJ 2002 Ligand-independent growth hormone receptor dimerization occurs in the endoplasmic reticulum and is required for ubiquitin system-dependent endocytosis. Proc Natl Acad Sci USA 99:9858-9863
9. Frank SJ, Gilliland G, Kraft AS, Arnold CS 1994 Interaction of the growth hormone receptor cytoplasmic domain with the JAK2 tyrosine kinase. Endocrinology 135:2228-2239
10. Sotiropoulos A, Perrot-Applanat M, Dinerstein H, Pallier A, Postel-Vinay MC, Finidori J, Kelly PA 1994 Distinct cytoplasmic regions of the growth hormone receptor are required for activation of JAK2, mitogen-activated protein kinase, and transcription. Endocrinology 135:1292-1298
11. Vanderkuur JA, Wang X, Zhang L, Campbell GS, Allevato G, Billestrup N, Norstedt G, Carter-Su C 1994 Domains of the growth hormone receptor required for association and activation of JAK2 tyrosine kinase. J Biol Chem 269:21709-21717
12. Frank SJ, Yi W, Zhao Y, Goldsmith JF, Gilliland G, Jiang J, Sakai I, Kraft AS 1995 Regions of the JAK2 tyrosine kinase required for coupling to the growth hormone receptor. J Biol Chem 270:14776-14785
13. Tanner JW, Chen W, Young RL, Longmore GD, Shaw AS 1995 The conserved box 1 motif of cytokine receptors is required for association with JAK kinases. J Biol Chem 270:6523-6530
14. He K, Wang X, Jiang J, Guan R, Bernstein KE, Sayeski PP, Frank SJ 2003 Janus kinase 2 determinants for growth hormone receptor association, surface assembly, and signaling. Mol Endocrinol 17:2211-2227
15. Brown RJ, Adams JJ, Pelekanos RA, Wan Y, McKinstry WJ, Palethorpe K, Seeber RM, Monks TA, Eidne KA, Parker MW, Waters MJ 2005 Model for growth hormone receptor activation based on subunit rotation within a receptor dimer. Nat Struct Mol Biol 12:814-821
16. Silva CM, Day RN, Weber MJ, Thorner MO 1993 Human growth hormone (GH) receptor is characterized as the 134-kilodalton tyrosine-phosphorylated protein activated by GH treatment in IM-9 cells. Endocrinology 133:2307-2312
17. Yi W, Kim SO, Jiang J, Park SH, Kraft AS, Waxman DJ, Frank SJ 1996 Growth hormone receptor cytoplasmic domain differentially promotes tyrosine phosphorylation of signal transducers and activators of transcription 5b and 3 by activated JAK2 kinase. Mol Endocrinol 10:1425-1443
18. Alele J, Jiang J, Goldsmith JF, Yang X, Maheshwari HG, Black RA, Baumann G, Frank SJ 1998 Blockade of growth hormone receptor shedding by a metalloprotease inhibitor. Endocrinology 139:1927-1935
19. Zhang Y, Jiang J, Black RA, Baumann G, Frank SJ 2000 TACE is a growth hormone binding protein sheddase: the metalloprotease TACE/ADAM-17 is critical for (PMA-induced) growth hormone receptor proteolysis and GHBP generation. Endocrinology 141:4324-4348
20. Guan R, Zhang Y, Jiang J, Baumann CA, Black RA, Baumann G, Frank SJ 2001 Phorbol ester- and growth factorinduced growth hormone (GH) receptor proteolysis and GH-binding protein shedding: relationship to GH receptor down-regulation. Endocrinology 142:1137-1147
21. Wang X, He K, Gerhart M, Jiang J, Paxton RJ, Menon RK, Black RA, Baumann G, Frank SJ 2003 Reduced proteolysis of rabbit growth hormone (GH) receptor substituted with mouse GH receptor cleavage site. Mol Endocrinol 17:1931-1943
22. Wang X, He K, Gerhart M, Huang Y, Jiang J, Paxton RJ, Yang S, Lu C, Menon RK, Black RA, Baumann G, Frank SJ 2002 Metalloprotease-mediated GH receptor proteolysis and GHBP shedding. Determination of extracellular domain stem region cleavage site. J Biol Chem 277:50510-50519
23. Loesch K, Deng L, Cowan JW, Wang X, He K, Jiang J, Black RA, Frank SJ 2006 JAK2 influences growth hormone receptor metalloproteolysis. Endocrinology 147:2839-2849
24. Strous GJ, van Kerkhof P 2002 The ubiquitin-proteasome pathway and the regulation of growth hormone receptor availability. Mol Cell Endocrinol 197:143-151
25. He K, Loesch K, Cowan JW, Li X, Deng L, Wang X, Jiang J, Frank SJ 2005 JAK2 enhances the stability of the mature GH receptor. Endocrinology 145:4755-4765
26. van Kerkhof P, Govers R, Alves dos Santos CM, Strous GJ 2000 Endocytosis and degradation of the growth hormone receptor are proteasome-dependent. J Biol Chem 275:1575-1580
27. van Kerkhof P, Sachse M, Klumperman J, Strous GJ 2001 Growth hormone receptor ubiquitination coincides with recruitment to clathrin-coated membrane domains. J Biol Chem 276:3778-3784
28. Allevato G, Billestrup N, Goujon L, Galsgaard ED, Norstedt G, Postel-Vinay MC, Kelly PA, Nielsen JH 1995 Identification of phenylalanine 346 in the rat growth hormone receptor as being critical for ligand-mediated internalization and down-regulation. J Biol Chem 270:17210-17214
29. Strous GJ, van Kerkhof P, Govers R, Ciechanover A, Schwartz AL 1996 The ubiquitin conjugation system is required for ligand-induced endocytosis and degradation of the growth hormone receptor. EMBO J 15:3806-3812
30. Govers R, ten Broeke T, van Kerkhof P, Schwartz AL, Strous GJ 1999 Identification of a novel ubiquitin conjugation motif, required for ligand-induced internalization of the growth hormone receptor. EMBO J 18:28-36
31. Takagi K, Saito Y, Sawada JI 2001 Proteasomes are involved in the constitutive degradation of growth hormone receptors. Biol Pharm Bull 24:744-748
32. van Kerkhof P, Smeets M, Strous GJ 2002 The ubiquitin-proteasome pathway regulates the availability of the GH receptor. Endocrinology 143:1243-1252
33. Moulin S, Bouzinba-Segard H, Kelly PA, Finidori J 2003 Jak2 and proteasome activities control the availability of cell surface growth hormone receptors during ligand exposure. Cell Signal 15:47-55
34. Saito Y, Teshima R, Yamazaki T, Ikebuchi H, Sawada J 1994 Ligand-induced internalization and phosphorylation-dependent degradation of growth hormone receptor in human IM-9 cells. Mol Cell Endocrinol 106:67-74
35. Alves dos Santos CM, ten Broeke T, Strous GJ 2001 Growth hormone receptor ubiquitination, endocytosis, and degradation are independent of signal transduction via Janus kinase 2. J Biol Chem 276:32635-32641
36. Kohlhuber F, Rogers NC, Watling D, Feng J, Guschin D, Briscoe J, Witthuhn BA, Kotenko SV, Pestka S, Stark GR, Ihle JN, Kerr IM 1997 A JAK1/JAK2 chimera can sustain α and γ interferon responses. Mol Cell Biol 17:695-706
37. Zhang Y, Jiang J, Kopchick JJ, Frank SJ 1999 Disulfide linkage of growth hormone (GH) receptors (GHR) reflects GH-induced GHR dimerization. Association of JAK2 with the GHR is enhanced by receptor dimerization. J Biol Chem 274:33072-33084
38. Zhang Y, Guan R, Jiang J, Kopchick JJ, Black RA, Baumann G, Frank SJ 2001 Growth hormone (GH)-induced dimerization inhibits phorbol ester-stimulated GH receptor proteolysis. J Biol Chem 276:24565-24573
39. Chishti AH, Kim AC, Marfatia SM, Lutchman M, Hanspal M, Jindal H, Liu SC, Low PS, Rouleau GA, Mohandas N, Chasis JA, Conboy JG, Gascard P, Takakuwa Y, Huang SC, Benz Jr EJ, Bretscher A, Fehon RG, Gusella JF, Ramesh V, Solomon F, Marchesi VT, Tsukita S, Tsukita S, Hoover KB, et al 1998 The FERM domain: a unique module involved in the linkage of cytoplasmic proteins to the membrane. Trends Biochem Sci 23:281-282
40. Girault JA, Labesse G, Mornon JP, Callebaut I 1999 The N-termini of FAK and JAKs contain divergent band 4.1 domains. Trends Biochem Sci 24:54-57
41. Zhuang H, Patel SV, He TC, Sonsteby SK, Niu Z, Wojchowski DM 1994 Inhibition of erythropoietin-induced mitogenesis by a kinase-deficient form of Jak2. J Biol Chem 269:21411-21414
42. Govers R, van Kerkhof P, Schwartz AL, Strous GJ 1997 Linkage of the ubiquitin-conjugating system and the endocytic pathway in ligand-induced internalization of the growth hormone receptor. EMBO J 16:4851-4858
43. Hansen LH, Wang X, Kopchick JJ, Bouchelouche P, Nielsen JH, Galsgaard ED, Billestrup N 1996 Identification of tyrosine residues in the intracellular domain of the growth hormone receptor required for transcriptional signaling and Stat5 activation. J Biol Chem 271:12669-12673
44. Wang X, Darus CJ, Xu BC, Kopchick JJ 1996 Identification of growth hormone receptor (GHR) tyrosine residues required for GHR phosphorylation and JAK2 and STAT5 activation. Mol Endocrinol 10:1249-1260
45. Waxman DJ, Frank SJ 2000 Growth hormone action: signaling via a JAK/STAT-coupled receptor. In: Conn PM, Means A, eds. Principles of molecular regulation. Totowa, NJ: Humana Press; 55-83
46. Held MA, Cosme-Blanco W, Difedele LM, Bonkowski EL, Menon RK, Denson LA 2005 Alterations in growth hormone receptor abundance regulate growth hormone signaling in murine obstructive cholestasis. Am J Physiol Gastrointest Liver Physiol 288:G986-G993
47. King AP, Carter-Su C 1995 Dexamethasone-induced antagonism of growth hormone (GH) action by down-regulation of GH binding in 3T3-F442A fibroblasts. Endocrinology 136:4796-4803
48. Ji S, Guan R, Frank SJ, Messina JL 1999 Insulin inhibits growth hormone signaling via the growth hormone receptor/JAK2/STAT5B pathway. J Biol Chem 274:13434-13442
49. Ji S, Frank SJ, Messina JL 2002 Growth hormone-induced differential desensitization of STAT5, ERK, and Akt phosphorylation. J Biol Chem 277:28384-28393
50. Burke P, Schooler K, Wiley HS 2001 Regulation of epidermal growth factor receptor signaling by endocytosis and intracellular trafficking. Mol Biol Cell 12:1897-1910
51. Moutoussamy S, Renaudie F, Lago F, Kelly PA, Finidori J 1998 Grb10 identified as a potential regulator of growth hormone (GH) signaling by cloning of GH receptor target proteins. J Biol Chem 273:15906-15912
52. Stofega MR, Herrington J, Billestrup N, Carter-Su C 2000 Mutation of the SHP-2 binding site in growth hormone (GH) receptor prolongs GH-promoted tyrosyl phosphorylation of GH receptor, JAK2, and STAT5B. Mol Endocrinol 14:1338-1350
53. Ram PA, Waxman DJ 1999 SOCS/CIS protein inhibition of growth hormone-stimulated STAT5 signaling by multiple mechanisms. J Biol Chem 274:35553-35561
54. Du L, Frick GP, Tai LR, Yoshimura A, Goodman HM 2003 Interaction of the growth hormone receptor with cytokine-induced Src homology domain 2 protein in rat adipocytes. Endocrinology 144:868-876
55. Kim SO, Jiang J, Yi W, Feng GS, Frank SJ 1998 Involvement of the Src homology 2-containing tyrosine phosphatase SHP-2 in growth hormone signaling. J Biol Chem 273:2344-2354
56. Landsman T, Waxman DJ 2005 Role of the cytokine-induced SH2 domain-containing protein CIS in growth hormone receptor internalization. J Biol Chem 280:37471-37480
57. Zhang JG, Farley A, Nicholson SE, Willson TA, Zugaro LM, Simpson RJ, Moritz RL, Cary D, Richardson R, Hausmann G, Kile BJ, Kent SB, Alexander WS, Metcalf D, Hilton DJ, Nicola NA, Baca M 1999 The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation. Proc Natl Acad Sci USA 96:2071-2076
58. Kumar KG, Tang W, Ravindranath AK, Clark WA, Croze E, Fuchs SY 2003 SCF(HOS) ubiquitin ligase mediates the ligand-induced down-regulation of the interferon-α receptor. EMBO J 22:5480-5490
59. Kumar KG, Krolewski JJ, Fuchs SY 2004 Phosphorylation and specific ubiquitin acceptor sites are required for ubiquitination and degradation of the IFNAR1 subunit of type I interferon receptor. J Biol Chem 279:46614-46620
60. Li Y, Kumar KG, Tang W, Spiegelman VS, Fuchs SY 2004 Negative regulation of prolactin receptor stability and signaling mediated by SCF(β-TrCP) E3 ubiquitin ligase. Mol Cell Biol 24:4038-4048
61. Li Y, Clevenger CV, Minkovsky N, Kumar KG, Raghunath PN, Tomaszewski JE, Spiegelman VS, Fuchs SY 2006 Stabilization of prolactin receptor in breast cancer cells. Oncogene 25:1896-1902
62. Meyer L, Deau B, Forejtnikova H, Dumenil D, Margottin-Goguet F, Lacombe C, Mayeux P, Verdier F, β-Trcp mediates ubiquitination and degradation of the erythropoietin receptor and controls cell proliferation. Blood, in press
63. Marijanovic Z, Ragimbeau J, Kumar KG, Fuchs SY, Pellegrini S 2006 TYK2 activity promotes ligand-induced IFNAR1 proteolysis. Biochem J 397:31-38
64. Walrafen P, Verdier F, Kadri Z, Chretien S, Lacombe C, Mayeux P 2005 Both proteasomes and lysosomes degrade the activated erythropoietin receptor. Blood 105:600-608
65. Cowan JW, Wang X, Guan R, He K, Jiang J, Baumann G, Black RA, Wolfe MS, Frank SJ 2005 Growth hormone receptor is a target for presenilin-dependent gamma-secretase cleavage. J Biol Chem 280:19331-19342
66. Strack B, Calistri A, Accola MA, Palu G, Gottlinger HG 2000 A role for ubiquitin ligase recruitment in retrovirus release. Proc Natl Acad Sci USA 97:13063-13068
67. Jiang J, Liang L, Kim SO, Zhang Y, Mandler R, Frank SJ 1998 Growth hormone-dependent tyrosine phosphorylation of a GH receptor-associated high molecular weight protein immunologically related to JAK2. Biochem Biophys Res Commun 253:774-779
68. Leung DW, Spencer SA, Cachianes G, Hammonds RG, Collins C, Henzel WJ, Barnard R, Waters MJ, Wood WI 1987 Growth hormone receptor and serum binding protein: purification, cloning and expression. Nature 330:537-543
69. Sayeski PP, Ali MS, Safavi A, Lyles M, Kim SO, Frank SJ, Bernstein KE 1999 A catalytically active Jak2 is required for the angiotensin II-dependent activation of Fyn. J Biol Chem 274:33131-33142
70. Saharinen P, Ekman N, Sarvas K, Parker P, Alitalo K, Silvennoinen O 1997 The Bmx tyrosine kinase induces activation of the Stat signaling pathway, which is specifically inhibited by protein kinase Cδ. Blood 90:4341-4353
71. Jiang J, Wang X, He K, Li X, Chen C, Sayeski PP, Waters MJ, Frank SJ 2004 A conformationally-sensitive GHR [growth hormone (GH) receptor] antibody: impact on GH signaling and GHR proteolysis. Mol Endocrinol 18:2981-2996